Background The outcome of parathyroid surgery is often not clear for at least 24 h after the operation. A frozen section does not always distinguish between an adenoma and hyperplasia. Minimally invasive surgical techniques are being refined, so the need for perioperative assurance about the completeness of surgery has increased. The value of intraoperative parathyroid hormone (PTH) measurements in 26 surgical cases undergoing parathyroidectomy has been evaluated.
Introduction
Primary hyperparathyroidism (HPT) is a common condition with most patients diagnosed by a blood test before they develop clinical symptoms.
HPT is rare below the age of 50 years but rises thereafter, particularly in women. 1 Clinical manifestations of HPT include renal calculi, osteoporosis and other non-speci¢c symptoms. The diagnosis is based on ¢nding hypercalcaemia with an inappropriately high PTH concentration.
Symptomatic patients and patients without symptoms but with serum calcium above 2.7 mmol/L or aged less than 50 years old should be o¡ered surgery.
Surgery o¡ers the only de¢nitive treatment for patients with HPT. 2 The most common parathyroid abnormality causing HPT is a solitary adenoma. Multiple gland disease occurs in about 17% of patients. 3 Multiple adenomas and hyperplasia occur more frequently in patients with multiple endocrine neoplasia (MEN) I or II and in patients with familial HPT. Parathyroid cancer is extremely rare, contributing less than 1% to incidence of HPT. The goal of parathyroidectomy is to establish normocalcaemia with minimal complications (these include persistent or recurrent hyperparathyroidism, postoperative transient or persistent hypoparathyroidism and recurrent laryngeal nerve injury).
The gold standard in parathyroid surgery is the fourgland exploration, a safe procedure with a success rate exceeding 95% for single-gland disease. 4--6 The surgeon locates the four parathyroid glands, estimate their sizes and determines if any glands are abnormal. A frozen section con¢rms that the excised tissue is parathyroid. Di⁄culties arise because hyperplasia can have a histological similarity to adenomas.The surgeon now has available preoperative localization techniques such as ultrasound and technetium-99M sestamibi imaging. 7 Magnetic resonance imaging (MRI), computed tomography (CT) and angiography are reserved for re-do patients whose initial parathyroid surgery was unsuccessful. Preoperative localization techniques can be combined with intraoperative PTH measurements 8--10 to rapidly locate and remove abnormal parathyroid glands without the need for neck exploration and intraoperative assessment of the remaining parathyroid glands. PTH monitoring during the surgical procedure can con¢rm removal of all hyperfunctioning parathyroid tissue, as the half-life of PTH is approximately 5 min. To con¢rm success of the surgical procedure a decrease in PTH concentration to at least 50% of the pre-incision value or the PTH concentration at removal of the suspected abnormal gland (T ¼ 0) can predict postoperative normocalcaemia. 11--13 Continued raised PTH concentrations post gland removal directs the surgeon to examine any additional parathyroid glands for other sources of PTH, including ectopic sources. The use of intraoperative PTH measurements reduces the operating time because the e¡ectiveness of surgery can be established rapidly. Intraoperative PTH measurements can also help reduce surgical and anaesthetic complications and re-exploration rate. The cost of equipment and assay kits for hormone measurements is justi¢ed by savings from a successful operation and short stay after the procedure compared with the costs of re-admission and repeat surgery.
Patients and methods

Patients
The study group consisted of 26 patients (19 women and 7 men). The mean age was 51.3 years (range 10--75 years). All patients underwent preoperative ultrasound and sestamibi technetium-99 imaging to localize parathyroid adenomas and discriminate between single-and multiple-gland pathology. In all, 21 of the patients in the study group were diagnosed as having primary hyperparathyroidism (PHPT), including two patients with MEN I. The remaining ¢ve patients had tertiary hyperparathyroidism, four had renal hyperparathyroidism (RHPT) and one patient had X-linked hypophosphataemia (X-HP). Table1shows preoperative clinical details of the study group.
Methods
Samples for analysis of PTH were taken into EDTA vacutainer tubes at the onset of surgery (pre-incision), at the time of tumour resection, at 5-min intervals following the removal of the tumour and at other time points as deemed necessary. Samples were centrifuged for 5 min at 3000 rpm. The PTH assay was performed using the Immulite-automated immunoassay analyser (Diagnostic Products Corporation [DPC], CA, USA). The PTH turbo assay is a solid-phase two-site chemiluminescent immunometric assay. The ¢rst antibody is a polyclonal goat anti-PTH (44--84) antibody coated on polystyrene beads. The second antibody is goat anti-PTH (1--34) conjugated to alkaline phosphatase. The turbo PTH assay processes samples at an accelerated rate. The time to ¢rst result is 15 min, allowing a quick turnaround time for PTH results to be communicated to the surgeon.
Results
Of the 26 patients undergoing routine parathyroidectomy, 15 patients were found to have single-gland disease, four patients had double adenomas and seven patients underwent total parathyroidectomies for hyperplasia ( Table 2) . Eleven patients were hypocalcaemic (calcium o2.15 mmol/L) postoperatively and subsequently became normocalcaemic. Two patients were hypercalcaemic (calcium 42.55 mmol/L) postoperatively. In one patient the preoperative calcium was 3.69 mmol/L and had fallen to 2.62 mmol/L postoperatively. This patient is now normocalcaemic. The second patient with postoperative hypercalcaemia had MEN I. Four glands were removed, but the patient remained hypercalcaemic and required a second operation during which a ¢fth parathyroid was removed from the mediastinum.
To con¢rm the success of the surgical procedure, a decrease in PTH concentration to less than 50% of the pre-incision value or less than 50% of the time of resection (t ¼ 0) value is required. During the surgical procedure plasma PTH concentration followed one of several patterns of decline depending on whether single-or multiple-gland disease was present (Figure1). Figure 1a shows an increase in PTH levels from baseline to gland removal, then a subsequent decline to a level less than 50% of the resection level. The increase in PTH concentration from pre-incision to resection was due to parathyroid gland manipulation. This patient had a right lower adenoma removed and is normocalcaemic to date. Figure 1b clearly showed a greater than 50% decline in PTH concentration from the baseline level to gland removal (t ¼ 0), presumably due to devascularization during dissection. Intraoperative PTH monitoring identi¢ed that the procedure was successful. The patient had a single adenoma removed and remains normocalcaemic to date. Figure 1c shows the decline in PTH concentration in a patient with multigland disease. A slight increase in PTH concentration was seen, presumably due to gland manipulation. An appropriate decrease in PTH concentration was observed between t=À10 and t=0. This corresponds to the removal of an upper left adenoma. On continued measurement of PTH concentration, a further rise was noted. During further surgical investigation, hyperfunctioning tissue was found in the right lobe of the thyroid. This was removed and PTH concentration subsequently declined. Figure 2 shows the intraoperative PTH pro¢le from a patient undergoing four-gland removal for RHPT (2a) and two related cases of MEN I (2b,2c). Figure 2(a) illustrates the time course of PTH decline as each parathyroid gland was removed during four gland parathyroidectomy. Figure 2(b) shows the intraoperative PTH pro¢le from a patient with MEN I. This patient had previously undergone parathyroid surgery and was symptomatic. An initial increase in PTH concentration was seen, presumably due to gland manipulation followed by a fall in PTH concentration to exactly 50% of the highest value (t ¼ 0). This 
Discussion
Currently, the success rate of parathyroidectomy is greater than 95% in centres experienced in this procedure and complications are rare. Success rates are lower in patients with familial hyperparathyroidism, parathyroid cancer and parathyromatosis. 14 The combination of improved preoperative imaging and intraoperative PTH measurements can decrease the operating time, decrease complications and allow a less invasive approach. This profile was obtained from a patient with MEN I. This patient had previously undergone parathyroid surgery and was symptomatic. An initial increase in PTH concentration is seen, followed by decline in PTH concentration to exactly 50% of the highest initial value. (c) This patient was related to the above case (b), who was also diagnosed with MEN I. The PTH concentration initially increases before an appropriate decrease in PTH concentration, consistent with removal of hyperfunctioning parathyroids. However, the PTH concentration increases again and remained elevated. Despite further surgical exploration, no other hyperfunctioning tissue could be found and the patient was sent to recovery. This profile represents a failed parathyroidectomy. The patient remained symptomatic and recently went back to theatre for completion of parathyroidectomy.
In our small retrospective study we looked at 26 parathyroidectomies; other larger prospective studies have been reported, 15--18 including patients with single and multigland disease, MEN I and RHPT. During parathyroidectomy, a decrease in PTH concentration is expected as the hypersecretory tissue is removed. At present there are no guidelines recommending the percentage decrease in PTH concentration to lead to a satisfactory patient outcome. There are many suggestions for the appropriate time to take samples for PTH measurement post-abnormal gland removal. Some investigators 19, 20 looked for a 50% decrease in PTH concentration at 5 min post-gland removal compared with the pre-incision value. Others suggested PTH measurement pre and 10 min post gland removal 4, 21 and also pre, 5 and 15 min post gland removal. 22, 23 In view of our experience in this small study, we would recommend monitoring PTH until at least 15 min post-gland removal in cases of suspected single adenoma to avoid false positives. False positives have been reported 24 in three cases when measuring PTH pre, 5 min and the next day postoperatively. There was an appropriate fall in PTH concentration at 5 min but PTH was increased the next day. One of the patients had multigland disease, two had resection of the thyroid gland to try and locate the adenoma. It is known that intraoperative PTH measurements may falsely predict surgical cure when parathyroidectomy is carried out simultaneously with resection of the thyroid gland. A fall in PTH concentration of greater than 50% may be seen after resection of thyroid nodules but before the removal of the single adenoma. This may be due to ligation of the blood supply to the parathyroid glands that originates from the inferior thyroid artery. Had the investigators extended the PTH sampling time in these three cases, the falsepositive outcomes would have been avoided.
If we applied the decision level of 50% decrease at 5 or 10 min post-gland removal, then some multigland cases would have been unsuccessful. If the PTH is still raised at 20 min even though there has been an appropriate decrease, further neck exploration should be instigated for the continued source of PTH as the patient may have multigland disease or an ectopic source.
The success of parathroidectomy also depends on accurate preoperative localization studies. As reported in one of our MEN I patients, a ¢fth parathyroid gland in the mediastinum was missed by sestamibi and ultrasound localization. Sestamibi imaging has a sensitivity and speci¢city of 83% 17 and is more accurate in patients with PHPT than those with secondary or tertiary hyperparathyroidism. Repeat sestamibi imaging and MRI successfully located the mediastinal parathyroid gland before repeat parathyroidectomy.
We therefore recommend caution when interpreting intraoperative PTH measurements to ensure a successful outcome. With continued improvements in preoperative localization of abnormal parathyroid glands, surgeons are moving towards less invasive approaches, such as minimally invasive parathyroidectomy. The use of imaging and intraoperative PTH monitoring can lead to decreased laboratory and surgical costs by facilitating concise parathyroid surgery.
